Neumora Therapeutics (NMRA) Non Operating Income (2022 - 2026)

Neumora Therapeutics' Non Operating Income history runs 5 years deep, the most recent figure standing at -$564000.0 for Q1 2026.

• In Q1 2026, Non Operating Income fell 2156.0% year-over-year to -$564000.0; the TTM figure through Mar 2026 stood at -$5.3 million (down 156.64% YoY), while the FY2025 annual figure was -$767000.0, down 883.33% from the prior year.
• Non Operating Income was -$564000.0 for Q1 2026 at Neumora Therapeutics, up from -$6.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $6.4 million in Q1 2024 to a low of -$6.1 million in Q4 2025.
• Historically, Non Operating Income has averaged $1.3 million across 5 years, with a median of $15000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Non Operating Income jumped 24534.62% in 2024, then plunged 40733.33% in 2025.
• A 5-year view of Non Operating Income shows it stood at -$2.0 million in 2022, then surged by 378.63% to $5.5 million in 2023, then sank by 99.73% to $15000.0 in 2024, then slumped by 40733.33% to -$6.1 million in 2025, then jumped by 90.75% to -$564000.0 in 2026.
• The last three Non Operating Income figures came in at -$564000.0 (Q1 2026), -$6.1 million (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.